Efficacy, safety and tolerability of cotadutide as an add-on therapy in overweight subjects with type 2 diabetes treated with dapagliflozin and metformin

被引：0
|
作者：
Flor, A. [1 ]
Petrone, M. [2 ]
Sanchez, J. [3 ]
Petrohoy, T. [4 ]
Jermutus, L. [2 ]
Hansen, L. [1 ]
Ambery, P. [3 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Gothenburg, Sweden
[4] Pfizer, Collegeville, PA USA
来源：
DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
476
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [31] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
    Bailey, C. J.
    Gross, J. L.
    Bastone, L.
    Bastien, A.
    List, J. F.
    DIABETOLOGIA, 2009, 52 : S76 - S76
  • [32] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
    Frias, Juan P.
    Gonzalez-Galvez, Guillermo
    Johnsson, Eva K.
    Maaske, Jill
    Peters, Anne
    DIABETES, 2018, 67
  • [33] Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy
    Barnett, A. H.
    Charbonnel, B.
    Li, J.
    Donovan, M.
    Fleming, D.
    DIABETOLOGIA, 2011, 54 : S108 - S109
  • [34] Efficacy and Safety of Add-On Vildagliptin to Metformin in Comparison to Uptitrating Metformin Therapy
    Kim, Nan Hee
    Sung, Yeon-Ah
    Ahn, Chul Woo
    Park, Seok Won
    Lim, Soo
    Kim, Chul Hee
    Kim, Dong Sun
    Shin, Young Goo
    Ahn, Kyu Jeung
    Kim, Jae Hyeon
    Baik, Sei Hyun
    DIABETES, 2012, 61 : A297 - A297
  • [35] Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy
    Barnett, Anthony H.
    Charbonnel, Bernard
    Li, Jia
    Donovan, Mark
    Fleming, Douglas
    Iqbal, Nayyar
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 707 - 717
  • [36] Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy
    Anthony H. Barnett
    Bernard Charbonnel
    Jia Li
    Mark Donovan
    Douglas Fleming
    Nayyar Iqbal
    Clinical Drug Investigation, 2013, 33 : 707 - 717
  • [37] Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
    Dharmalingam, Mala
    Sharma, Surendra Kumar
    Prakash, Ved
    Maiti, Animesh
    Kumar, Ritesh
    Murthy, Laxminarayanappa Sreenivasa S.
    Ramanathan, Balamurugan
    Maheshwari, Sanjiv
    Kethavath, Sunil Naik
    Ogale, Dhananjay
    Bachubhai, Prajapati Vipul Kumar
    Sonawane, Ashutosh B.
    Shah, Vaishal
    Suresh, Manjula
    Chakraborty, Sisir
    Manjunath, Krishna Kumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [38] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    DIABETES, 2016, 65 : A293 - A293
  • [39] Add-on therapies to metformin for type 2 diabetes
    Shomali, Mansur
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) : 47 - 62
  • [40] CHOICE OF THE ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN ROMANIA
    Brozi, J.
    Brunerova, L.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (03) : 375 - 375
12345